Demonstrates effective antibiotics degradation in wastewater using optimized biochar.
Biochar optimized with oxygen-containing functional groups is believed to be beneficial for peroxymonosulfate (PMS) activation, and biochar-loaded Co 3 O 4 -based catalysts are expected to be one of the most promising PMS activators for the efficient removal of organic pollutants. Nevertheless, the real active sites on Co 3 O 4 catalysts are still in debate due to insufficient experimental evidence. Herein, Co 3 O 4 growing on the oxygen-containing functional groups optimized rice husk biochar (RHBA) was synthesized (RHBA@Co 3 O 4 ), and RHBA800@25Co 3 O 4 + PMS system achieved complete degradation (100%) of refractory levofloxacin (LFX) within 4 min. The superior catalytic performance was suggested to be attributed not only to the uniform dispersion of Co 3 O 4 , but also to the transformation of lattice oxygen in Co 3 O 4 , which was found to play an important role in the catalytic process by inducing the formation of Co 3 O 4−α –OH. Meanwhile, density functional theory (DFT) calculations indicated that the adsorption energy ( E ads ) of PMS on Co 3 O 4−α –OH was far lower than that on Co 3 O 4 . Moreover, both radical and non-radical pathways were indicated to be involved during the degradation process. Additionally, the practical application of RHBA@Co 3 O 4 was investigated using various antibiotics, actual water environments, and fixed-bed reactors. The results showed that it possessed good practical degradation performance and significantly reduced the toxicity of intermediate products. This work provides a fresh insight into the catalytic mechanism of RHBA800@25Co 3 O 4 for PMS activation and wastewater treatment, offering a new perspective on the catalytic mechanism of Co 3 O 4 -based materials. Highlights RHBA800@25Co 3 O 4 exhibited ultrafast antibiotics degradation via peroxymonosulfate activation. Inspired formation of Co 3 O 4−α –OH by lattice oxygen induction was explored. Ecological safety of levofloxacin degradation products was verified through antibacterial experiments.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: